Now Open: DDW® 2025 Abstract Submission Period
Present your research at the premier event in GI and hepatology! Submissions are due Dec. 5.
Present your research at the premier event in GI and hepatology! Submissions are due Dec. 5.
September is Women in Medicine Month! Check out some of our amazing faculty from DDW 2024 and their contributions to the field.
Don’t miss seeing where science is headed in your specialty and the wider field this year. DDW On Demand is now on sale.
Suggest a session topic by June 15, 2024, for a chance to assist in creating the 2025 program.
A new appreciation for the impact of metabolic risk factors in ALD may open avenues for new treatments.
The proposal focuses on establishing point-of-care testing, increasing medication access among underserved populations, and engaging community organizations to drive awareness and increase screening.
A retrospective cohort study shows that GLP-1 agonists reduced the risk of cirrhosis and HCC in patients with MASLD and Type 2 diabetes.
New AASLD guidelines broadly recommend simple, cost-effective blood-based tests and elastography for many patients with chronic liver disease.
Your DDW 2024 registration includes unlimited access to session recordings until May 16, 2025.
DDW 2024 is certified for 647.5 AMA PRA Category 1 Credit(s)™. The CME Claim Site will be open through Oct. 31.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.